Surmodics | SRDX - Debt


Surmodics reported $29.55M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Abbott USD 13.86B 919M Dec/2025
Align Technology USD 114.45M 6.82M Dec/2025
Anika Therapeutics USD 0 0 Mar/2025
Arrowhead Research USD 312.77M 53.52M Dec/2025
Artivion USD 317.78M 619K Dec/2024
Baxter International USD 9.78B 68M Dec/2025
Boston Scientific USD 11.44B 610M Dec/2025
EDAP TMS EUR 7.55M 1.41M Sep/2025
Edwards Lifesciences USD 600M 105.4M Mar/2026
Haemonetics USD 1.22B 5K Dec/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
J&J USD 47.93B 2.14B Dec/2025
Merit Medical Systems USD 821.57M 420K Dec/2025
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Nektar Therapeutics USD 0 0 Jun/2022
Option Care Health USD 1.15B 1.01M Mar/2026
Stryker USD 14.22B 635M Mar/2026
Surmodics USD 29.55M 111K Sep/2024
Trinity Biotech USD 100.76M 7.05M Dec/2024